Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03903731 · ClinicalTrials.gov registry record
Safety and Performance of Journey II BCS Total Knee System Patient Reported Outcome Measures
A clinical trial of Journey II BCS Total Knee System, sponsored by Smith & Nephew.
- Completed
- Registry status
- 600
- Enrollment target
- 5
- Study locations
NCT03903731: Completed study of Journey II BCS Total Knee System, sponsored by Smith & Nephew.
NCT03903731 is a study of Journey II BCS Total Knee System that has completed, run by Smith & Nephew. The registered enrollment target is 600 participants. The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03903731, a study of Journey II BCS Total Knee System, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
- 5
- Study locations
Study Summary
Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcome Measures.
Primary Outcome
We are measuring the number of revision cases
Conditions Studied
Interventions
- DEVICE Total knee arthroplasty with Journey II BCS Total Knee System
Study Locations (5)
Other
- UZ Leuven - Leuven
- Anglesea Clinic Orthopaedics - Hamilton
Colorado
- Department of Orthopaedics, University of Colorado Denver - Aurora
New York
- Hospital for Special Surgery - New York
Tennessee
- Tennessee Orthopaedic Clinics - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2018-07-19 |
| Est. Completion | 2019-08-08 |
What the finished NCT03903731 record still lists
NCT03903731 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Journey II BCS Total Knee System appearing as the primary indexed condition, and to 1 intervention - of which Total knee arthroplasty with Journey II BCS Total Knee System is the first listed.
NCT03903731 lists 5 locations in 4 states (Other, Colorado, New York).
Frequently Asked Questions
What is clinical trial NCT03903731 about?
NCT03903731 is a clinical study titled "Safety and Performance of Journey II BCS Total Knee System Patient Reported Outcome Measures". Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcome Measures.
What is the current status of trial NCT03903731?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2018-07-19. Estimated completion is 2019-08-08.
What conditions does trial NCT03903731 study?
This clinical trial studies the following conditions: Journey II BCS Total Knee System.
What interventions are being tested in trial NCT03903731?
The interventions under investigation include: Total knee arthroplasty with Journey II BCS Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT03903731?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03903731 being conducted?
This trial has 5 study locations across Colorado, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI